SooChow Securities
VC Fund
Suzhou, China
SooChow Securities is a VC fund in Suzhou focused on Manufacturing and Electronics. SooChow Securities provides asset management, fixed-income investing, margin financing, and wealth management. They offer a support system of research consulting, information technology, and risk management, creating a win-win cooperative future for customers.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries SooChow Securities invests in
Stages SooChow Securities invests in
Countries SooChow Securities invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Manufacturing 4 (22%)
- Electronics 3 (17%)
- Semiconductor 3 (17%)
- Medical 2 (11%)
- Security 2 (11%)
Stage
- Post-IPO Equity 6 (33%)
- Series B 5 (28%)
- Angel 2 (11%)
- Seed 1 (6%)
- Series A 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Guo Jingjing
Head of Equity Investment
|
Head of Equity Investment | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Zhongchuding Construction Group
|
Zhongchuding Construction Group is a company that provides intelligent construction technology solutions. | $2.7M / Angel / Apr 15, 2025 | |
Keyang Semiconductor
|
Keyang is mainly engaged in the design, R&D, manufacture, packaging, and testing of semiconductor TSV package integrated circuit products. | $72.7M / Venture - Series Unknown / Apr 03, 2023 | |
Lilong Semiconductor
|
LEKIN is a developer of optoelectronic compound semiconductor products. | $13.1M / Series A / Apr 03, 2023 | |
Jiangsu Jing Chuang Advanced Electronic Technology
|
Jiangsu Jing Chuang Advanced Electronic Technology specializes in the research and development of semiconductor material cutting equipment. | Series B / Mar 08, 2023 | |
Biosun Pharma
|
Biosun Pharma is an innovative biopharmaceutical company that specializes in the production of drugs for tumors, self-immune diseases, and inflammatory diseases. | Series B / Jan 09, 2023 | |
OpenPie
|
OpenPie was established in 2021 with the mission of "Data Computing for New Discoveries" and "Data Computing, Only for New Discoveries", hoping to build an innovation-driven organization in the field of basic data computing that is based in China and faces the world. | Seed / Jun 23, 2022 | |
Regend Therapeutics
|
Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company inChina to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem cells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health. | $15.8M / Series B / Mar 03, 2022 | |
Tianbing Technology
|
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meetcost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system. | $15.7M / Series B / Feb 09, 2022 | |
Zhongzhi.CN
|
Zhongzhi.CN is an electronic business platform. They also provide information, promotion, warehouse, and logistic services. Additionally, they also provide cultural paper, wrapping paper, pulp, waste paper, and tissue paper services. | $1.8M / Post-IPO Equity / Jun 15, 2016 | |
Ailifang
|
Ailifang provides childhood education services. They also offer business philosophy, vigorously promote research and development, marketing, training, supply, and management services. | $1.8M / Post-IPO Equity / Apr 27, 2016 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SooChow Securities invest in?
SooChow Securities invests primarily in Manufacturing, Electronics and Semiconductor startups, most often at Post-IPO Equity and Series B stage. Most of the 18 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SooChow Securities?
Public channels for SooChow Securities include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SooChow Securities?
The team at SooChow Securities includes Guo Jingjing (Head of Equity Investment). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
